Literature DB >> 16287448

The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity.

Alun W Thomas1, Andrea Cannon, Esther Bartlett, Julie Ellis-Jones, Paul Abrams.   

Abstract

OBJECTIVES: To assess the long-term symptomatic and urodynamic outcomes of men with untreated detrusor underactivity (DUA) as there has been little long-term follow-up information on men with DUA, a cause of lower urinary tract symptoms (LUTS) in a significant minority of men. PATIENTS AND METHODS: Neurologically intact men aged > 18 years who were investigated in our department between 1972 and 1986, diagnosed with DUA, and who initially opted for no specific treatment were invited for a repeat symptomatic and urodynamic evaluation. Identical methods of assessment were used, allowing results to be compared directly.
RESULTS: In all, 224 men were initially diagnosed with DUA; 87 (39%) of these died. Of the 69 men who initially opted for a conservative approach and attended for repeat assessment, 58 (84%) remained untreated, with a mean follow-up of 13.6 years. There were no significant changes in symptoms over the follow-up. The only significant urodynamic finding was an increase in the proportion of patients with detrusor overactivity, but with no apparent worsening of chronic retention. Of the 11 men in who failed the conservative approach, eight proceeded to surgery for LUTS, and three for acute urinary retention.
CONCLUSIONS: These results provide important information on the natural history of DUA. In men with DUA presenting with LUTS there are few symptomatic and urodynamic changes with time.

Entities:  

Mesh:

Year:  2005        PMID: 16287448     DOI: 10.1111/j.1464-410X.2005.05891.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

1.  [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Authors:  K Höfner; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; T Bschleipfer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 2.  Urodynamics: examining the current role of UDS testing. What is the role of urodynamic testing in light of recent AUA urodynamics and overactive bladder guidelines and the VALUE study?

Authors:  Elizabeth Timbrook Brown; Ryan M Krlin; J Christian Winters
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

3.  A new look at detrusor underactivity: impaired contractility versus afferent dysfunction.

Authors:  Anne M Suskind; Phillip P Smith
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 4.  Practical use of the new American Urological Association adult urodynamics guidelines.

Authors:  Bhavin N Patel; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 5.  Updates of underactive bladder: a review of the recent literature.

Authors:  Xing Li; Limin Liao
Journal:  Int Urol Nephrol       Date:  2016-03-01       Impact factor: 2.370

6.  Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated?

Authors:  Rubiao Ou; Chaojie Pan; Hui Chen; Suishan Wu; Xinghua Wei; Xiangrong Deng; Ping Tang; Keji Xie
Journal:  Int Urol Nephrol       Date:  2011-06-10       Impact factor: 2.370

Review 7.  Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016.

Authors:  Amir Noor; Aaron M Fischman
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

8.  Cluster analysis of men undergoing surgery for BPH/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility.

Authors:  Andrew J Schneider; Matthew Grimes; Will Lyon; Amanda Kemper; Sijian Wang; Wade Bushman
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

9.  Low-frequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency.

Authors:  Dan-Feng Xu; Shen Zhang; Cun-Zhou Wang; Jun Li; Chuang-Yu Qu; Xin-Gang Cui; Sheng-Jia Zhao
Journal:  Int Urogynecol J       Date:  2012-03-23       Impact factor: 2.894

10.  Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility.

Authors:  Chung-Cheng Wang; Cheng-Ling Lee; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-03-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.